Why Did Carlos Slim Buy PBF Energy?
Carlos Slim made a splash in a surprising sector last…
Sell
47
DRUG Quote, Financials, Valuation and Earnings
Last price:
$38.32
Seasonality move
:
-32.13%
Day range:
$34.79 - $42.47
52-week range:
$0.93 - $79.02
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
70.12x
Volume:
148.1K
Avg. volume:
139.8K
1-year change:
2135.94%
Market cap:
$287.3M
Revenue:
--
EPS (TTM):
-$0.68
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $264K | $5M | $9.5M | $3.7M | $867.2K | |
| Selling, General & Admin | $85.2K | $1.8M | $2M | $1.6M | $1.1M | |
| Other Inc / (Exp) | -- | $121.9K | $8K | $10.5K | -$6.8K | |
| Operating Expenses | $353.2K | $6.9M | $11.7M | $5.5M | $2.1M | |
| Operating Income | -$353.2K | -$6.9M | -$11.7M | -$5.5M | -$2.1M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$357.4K | -$6.8M | -$11.7M | -$5.5M | -$2.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$357.4K | -$6.8M | -$11.7M | -$5.5M | -$2.1M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$357.4K | -$6.8M | -$11.7M | -$5.5M | -$2.1M | |
| Basic EPS (Cont. Ops) | -$0.28 | -$3.81 | -$4.74 | -$1.47 | -$0.48 | |
| Diluted EPS (Cont. Ops) | -$0.28 | -$3.81 | -$4.74 | -$1.47 | -$0.48 | |
| Weighted Average Basic Share | $1.3M | $1.8M | $2.5M | $3.7M | $4.3M | |
| Weighted Average Diluted Share | $1.3M | $1.8M | $2.5M | $3.7M | $4.3M | |
| EBITDA | -$353.2K | -$6.9M | -$11.7M | -$5.4M | -$2M | |
| EBIT | -$353.2K | -$6.9M | -$11.7M | -$5.5M | -$2.1M | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -$353.2K | -$6.9M | -$11.7M | -$5.5M | -$2.1M | |
| Operating Income (Adjusted) | -$353.2K | -$6.9M | -$11.7M | -$5.5M | -$2.1M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $222.1K | $1.8M | $1.9M | $813.2K | $304.9K | |
| Selling, General & Admin | $71.8K | $591.5K | $330K | $342.1K | $257.2K | |
| Other Inc / (Exp) | -- | $79.1K | $38.4K | $43.2K | $8.7K | |
| Operating Expenses | $297.9K | $2.4M | $2.3M | $1.2M | $579.9K | |
| Operating Income | -$297.9K | -$2.4M | -$2.3M | -$1.2M | -$579.9K | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$302.1K | -$2.3M | -$2.3M | -$1.1M | -$566.8K | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$301.3K | -$2.1M | -$2.3M | -$1.1M | -$577K | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$302.1K | -$2.3M | -$2.3M | -$1.1M | -$566.8K | |
| Basic EPS (Cont. Ops) | -$0.24 | -$0.97 | -$0.77 | -$0.30 | -$0.12 | |
| Diluted EPS (Cont. Ops) | -$0.24 | -$0.97 | -$0.77 | -$0.30 | -$0.12 | |
| Weighted Average Basic Share | $1.3M | $2.4M | $2.8M | $3.8M | $4.5M | |
| Weighted Average Diluted Share | $1.3M | $2.4M | $2.8M | $3.8M | $4.5M | |
| EBITDA | -$297.9K | -$2.4M | -$2.3M | -$1.2M | -$565.9K | |
| EBIT | -$297.9K | -$2.4M | -$2.3M | -$1.2M | -$579.9K | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -$297.9K | -$2.4M | -$2.3M | -$1.2M | -$579.9K | |
| Operating Income (Adjusted) | -$297.9K | -$2.4M | -$2.3M | -$1.2M | -$579.9K | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $265.7K | $5.1M | $9.6M | $3.7M | $869K | |
| Selling, General & Admin | $85.5K | $1.8M | $2M | $1.6M | $1.1M | |
| Other Inc / (Exp) | -- | $125.7K | $6.7K | $10.9K | -$6.9K | |
| Operating Expenses | $355.3K | $7M | $11.7M | $5.5M | $2.1M | |
| Operating Income | -$355.3K | -$7M | -$11.7M | -$5.5M | -$2.1M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$359.5K | -$6.9M | -$11.7M | -$5.5M | -$2.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$357.4K | -$6.8M | -$11.7M | -$5.5M | -$2.1M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$359.5K | -$6.9M | -$11.7M | -$5.5M | -$2.1M | |
| Basic EPS (Cont. Ops) | -$0.28 | -$3.54 | -$4.78 | -$1.47 | -$0.51 | |
| Diluted EPS (Cont. Ops) | -$0.28 | -$3.54 | -$4.78 | -$1.47 | -$0.51 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -$355.3K | -$7M | -$11.7M | -$5.4M | -$2M | |
| EBIT | -$355.3K | -$7M | -$11.7M | -$5.5M | -$2.1M | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -$355.3K | -$7M | -$11.7M | -$5.5M | -$2.1M | |
| Operating Income (Adjusted) | -$355.3K | -$7M | -$11.7M | -$5.5M | -$2.1M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $5.1M | $9.6M | $3.7M | $869K | -- | |
| Selling, General & Admin | $1.8M | $2M | $1.6M | $1.1M | -- | |
| Other Inc / (Exp) | $125.7K | $6.7K | $10.9K | -$6.9K | -- | |
| Operating Expenses | $7M | $11.7M | $5.5M | $2.1M | -- | |
| Operating Income | -$7M | -$11.7M | -$5.5M | -$2.1M | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$6.9M | -$11.7M | -$5.5M | -$2.1M | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$6.8M | -$11.7M | -$5.5M | -$2.1M | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$6.9M | -$11.7M | -$5.5M | -$2.1M | -- | |
| Basic EPS (Cont. Ops) | -$3.54 | -$4.78 | -$1.47 | -$0.51 | -- | |
| Diluted EPS (Cont. Ops) | -$3.54 | -$4.78 | -$1.47 | -$0.51 | -- | |
| Weighted Average Basic Share | $7.3M | $9.9M | $14.9M | $17.2M | -- | |
| Weighted Average Diluted Share | $7.3M | $9.9M | $14.9M | $17.2M | -- | |
| EBITDA | -$7M | -$11.7M | -$5.4M | -$2M | -- | |
| EBIT | -$7M | -$11.7M | -$5.5M | -$2.1M | -- | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -$7M | -$11.7M | -$5.5M | -$2.1M | -- | |
| Operating Income (Adjusted) | -$7M | -$11.7M | -$5.5M | -$2.1M | -- | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $597.6K | $15.5M | $8.5M | $5M | $4.2M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $58.5K | $131.9K | $120.2K | $20.4K | $160.3K | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $656.1K | $15.7M | $8.7M | $5M | $4.4M | |
| Property Plant And Equipment | -- | -- | $101.5K | $48.9K | $87.1K | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $657.6K | $15.7M | $8.8M | $5.1M | $4.5M | |
| Accounts Payable | $103.4K | $467.7K | $911.4K | $134.1K | $301.7K | |
| Accrued Expenses | $9.3K | $32.9K | $115.7K | $18.4K | $30.9K | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | $49.7K | $54.1K | $58.8K | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $112.8K | $500.6K | $1.1M | $206.6K | $391.3K | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $112.8K | $500.6K | $1.1M | $206.6K | $420.6K | |
| Common Stock | $732.6K | $21.2M | $23.6M | $24.9M | $26.2M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $544.8K | $15.2M | $7.7M | $4.9M | $4.1M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $544.8K | $15.2M | $7.7M | $4.9M | $4.1M | |
| Total Liabilities and Equity | $657.6K | $15.7M | $8.8M | $5.1M | $4.5M | |
| Cash and Short Terms | $597.6K | $15.5M | $8.5M | $5M | $4.2M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $597.6K | $15.5M | $8.5M | $5M | $4.2M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $58.5K | $131.9K | $120.2K | $20.4K | $160.3K | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $656.1K | $15.7M | $8.7M | $5M | $4.4M | |
| Property Plant And Equipment | -- | -- | $101.5K | $48.9K | $87.1K | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $657.6K | $15.7M | $8.8M | $5.1M | $4.5M | |
| Accounts Payable | $103.4K | $467.7K | $911.4K | $134.1K | $301.7K | |
| Accrued Expenses | $9.3K | $32.9K | $115.7K | $18.4K | $30.9K | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | $49.7K | $54.1K | $58.8K | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $112.8K | $500.6K | $1.1M | $206.6K | $391.3K | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $112.8K | $500.6K | $1.1M | $206.6K | $420.6K | |
| Common Stock | $732.6K | $21.2M | $23.6M | $24.9M | $26.2M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $544.8K | $15.2M | $7.7M | $4.9M | $4.1M | |
| Total Liabilities and Equity | $657.6K | $15.7M | $8.8M | $5.1M | $4.5M | |
| Cash and Short Terms | $597.6K | $15.5M | $8.5M | $5M | $4.2M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$357.4K | -$6.8M | -$11.7M | -$5.5M | -$2.1M | |
| Depreciation & Amoritzation | -- | -- | $4.7K | $53.7K | $53.9K | |
| Stock-Based Compensation | $120K | $696.5K | $685K | $853.7K | $617.1K | |
| Change in Accounts Receivable | -- | -$87.1K | -$35.7K | $88K | -$9.7K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$214.6K | -$5.8M | -$10.6M | -$5.2M | -$1.4M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -$5.6K | -$63.8K | -$65.9K | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -$1.4M | -$626.2K | -$20K | -- | |
| Cash From Financing | $750.2K | $20.6M | $4.1M | $1.6M | $595.7K | |
| Beginning Cash (CF) | $59.5K | $632.7K | $15.5M | $8.6M | $5M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $535.6K | $14.8M | -$6.6M | -$3.6M | -$764K | |
| Ending Cash (CF) | $595.1K | $15.6M | $9.1M | $5M | $4.2M | |
| Levered Free Cash Flow | -$214.6K | -$5.8M | -$10.6M | -$5.2M | -$1.4M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$301.3K | -$2.1M | -$2.3M | -$1.1M | -$577K | |
| Depreciation & Amoritzation | -- | -- | $4.7K | $13.3K | $14.2K | |
| Stock-Based Compensation | $120K | $286.1K | $23.6K | $294.9K | $157.2K | |
| Change in Accounts Receivable | -- | -$23.6K | -$71.5K | $49.3K | -$24.2K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$158.5K | -$1.8M | -$1.7M | -$873.2K | -$346.3K | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | $19.4K | -$15.9K | -$17.8K | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | $42.1K | -$652.5K | $70 | -- | |
| Cash From Financing | $691.2K | -$615.3K | $4M | -$21.4K | -$13.8K | |
| Beginning Cash (CF) | $60.5K | $17.9M | $6.8M | $6M | $4.5M | |
| Foreign Exchange Rate Adjustment | -- | $118.8K | $40.3K | -$121.4K | $12.2K | |
| Additions / Reductions | $532.8K | -$2.4M | $2.3M | -$894.6K | -$360K | |
| Ending Cash (CF) | $595.1K | $15.6M | $9.1M | $5M | $4.2M | |
| Levered Free Cash Flow | -$158.5K | -$1.8M | -$1.7M | -$873.2K | -$346.3K | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$357.4K | -$6.8M | -$11.7M | -$5.5M | -$2.1M | |
| Depreciation & Amoritzation | -- | -- | $4.7K | $53.7K | $53.9K | |
| Stock-Based Compensation | $120K | $696.5K | $685K | $853.7K | $617.1K | |
| Change in Accounts Receivable | -- | -$87.1K | -$35.7K | $88K | -$9.7K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$214.6K | -$5.8M | -$10.6M | -$5.2M | -$1.4M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -$5.6K | -$63.8K | -$65.9K | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -$1.4M | -- | -$20K | -- | |
| Cash From Financing | $750.2K | $20.6M | $4.1M | $1.6M | $595.7K | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $535.6K | $14.8M | -$6.6M | -$3.6M | -$764K | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$214.6K | -$5.8M | -$10.6M | -$5.2M | -$1.4M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$6.8M | -$11.7M | -$5.5M | -$2.1M | -- | |
| Depreciation & Amoritzation | -- | $4.7K | $53.7K | $53.9K | -- | |
| Stock-Based Compensation | $696.5K | $685K | $853.7K | $617.1K | -- | |
| Change in Accounts Receivable | -$87.1K | -$35.7K | $88K | -$9.7K | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$5.8M | -$10.6M | -$5.2M | -$1.4M | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -$5.6K | -$63.8K | -$65.9K | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$1.4M | -$626.2K | -$20K | -- | -- | |
| Cash From Financing | $20.6M | $4.1M | $1.6M | $595.7K | -- | |
| Beginning Cash (CF) | $40.2M | $43.5M | $30M | $18.8M | -- | |
| Foreign Exchange Rate Adjustment | $177K | $202.6K | -$33.6K | $8.6K | -- | |
| Additions / Reductions | $14.8M | -$6.6M | -$3.6M | -$764K | -- | |
| Ending Cash (CF) | $55.2M | $36.9M | $26.4M | $18.1M | -- | |
| Levered Free Cash Flow | -$5.8M | -$10.6M | -$5.2M | -$1.4M | -- | |
Get DRUG Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
DRUG
Sector
P/E ratio
--
25.45x
PEG ratio
--
0.00x
P/B ratio
70.12x
1.86x
Price / LTM sales
--
1.87x
Growth Metrics
DRUG
Sector
Revenue growth
--
7.24%
Earnings growth
--
1.42%
Revenue (5-year growth)
--
8.74%
Earnings forecast
--
-$0.18
Profitability
DRUG
Sector
Profitability FY 2024
--
$57.2M
Return on invested capital
--
-14.35%
Return on assets
--
-11.82%
Return on equity
--
-15.2%
Earnings Date
Last Earnings Date
Feb
14
Next Earnings Date
Jan
3
Estimated Next Earnings Date
Apr
4
Balance Sheet
DRUG
Sector
Total cash
$4.5M
$46.4M
Short term investments
--
$44M
Total assets
$4.5M
$139.8M
Long term debt
--
$6.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Booking Holdings Stock Undervalued?
There is a lot of humdrum in the market about…
Broadcom vs American Express: Which Is Best?
Chip giant Broadcom Inc. (NASDAQ:AVGO) and card company American Express…
Stock Ideas
Sell
48
Is AAPL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 40x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 116x
Sell
43
Is MSFT Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Sell
47
DRUG alert for Jan 3
Bright Minds Biosciences [DRUG] is down 4.72% over the past day.
Buy
88
BMA alert for Jan 3
Banco Macro SA [BMA] is up 0.59% over the past day.
Sell
50
AGFY alert for Jan 3
Agrify [AGFY] is down 5.83% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
